Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study (Q34584163)
scientific article
Language:
Current Data About Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study
(P31) (Q13442814)
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

(P50) (Q42721742)
(P1545) 7
(P1932) Robert J Motzer
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

(Q5546267)
(P1545) 4
(P1932) George Wilding
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

(Q73568053)
(P1545) 1
(P1932) Olivier Rixe
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

(P304) 975-984
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

(P433) 11
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

(P478) 8
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

(P577) Tuesday, October 23, 2007
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

(P921) (Q181600)

(P1433) (Q13747613)
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

(P1476) "Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study" (language: en)
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

(P2093) Ronald M Bukowski
(P1545) 2
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

M Dror Michaelson
(P1545) 3
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

Gary R Hudes
(P1545) 5
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

Oliver Bolte
(P1545) 6
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

Paul Bycott
(P1545) 8
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

Katherine F Liau
(P1545) 9
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

James Freddo
(P1545) 10
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

Peter C Trask
(P1545) 11
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

Sinil Kim
(P1545) 12
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

Brian I Rini
(P1545) 13
(P248)
(P698) 17959415
(P813) Thursday, August 3, 2017

(P2860) (Q29615133)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

(Q34293726)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

(Q35943769)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

(Q35052385)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

(Q28262507)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

(Q27860904)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

(Q29615701)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

(Q53584979)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

(Q36509678)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

(Q46837791)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

(Q28282767)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

(Q28282757)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

(Q58214894)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

(Q50730548)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970285-1
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article

External Links
(P356) 10.1016/S1470-2045(07)70285-1
(P698) 17959415